Intravitreal bevacizumab for diabetic papillopathy
     
Yazarlar (2)
Prof. Dr. Kemal ÖRNEK Kirikkale Üniversitesi, Türkiye
Tevfik Oğurel Kirikkale Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Journal of Ocular Pharmacology and Therapeutics
Dergi ISSN 1080-7683 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI
Makale Dili İngilizce Basım Tarihi 04-2010
Cilt / Sayı / Sayfa 26 / 2 / 217–218 DOI 10.1089/jop.2009.0125
Özet
A 43-year-old woman presented with a visual acuity of 1/10 in the right eye and 3/10 in the left eye. Ophthalmologic examination disclosed optic disc swelling on both sides with mild nonproliferative diabetic retinopathy. The pupils were equal and reactive without an afferent pupillary defect. Visual field testing showed no significant defect in both eyes. Systemic investigations revealed no abnormality. The patient was injected with bevacizumab intravitreally with the diagnosis of diabetic papillopathy (DP). Three weeks later, the vision increased to 7/10 in the right eye and optic disc edema disappeared. Intravitreal injection of bevacizumab effectively treated DP.
Anahtar Kelimeler
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
WoS 10
SCOPUS 13
Google Scholar 25
Intravitreal bevacizumab for diabetic papillopathy

Paylaş